ClinConnect ClinConnect Logo
Search / Trial NCT05206838

Achilles Tendon for the Treatment of Gluteus Medius Insufficiency

Launched by SAHLGRENSKA UNIVERSITY HOSPITAL · Jan 11, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Gluteus Medius Limp Abductor Trendelenburg

ClinConnect Summary

This clinical trial is looking at a new surgical treatment to help people who have trouble walking (or limping) after having hip replacement surgery. Sometimes, even after the surgery, people continue to experience limping due to weakness or injury in a muscle called the gluteus medius. This study aims to see if surgery, followed by physical therapy, can improve hip function and reduce limping more effectively than just physical therapy alone.

To participate in this trial, you may be eligible if you have had persistent limping for at least a year after your hip replacement and an injury to the gluteus medius muscle that has been confirmed by an ultrasound or MRI. You should also have only a small difference in leg length or hip measurements. Participants will receive either the surgical treatment or continue with non-surgical therapy, and all will engage in physical therapy to aid recovery. This study is currently recruiting participants, and it's open to anyone aged 18 and older, regardless of gender.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Persisting limping with positive Trendelenburg's sign for at least 12 months after total hip arthroplasty
  • Rupture/avulsion of the gluteus medius tendon verified with ultrasound or MRI
  • Leg length discrepancy of less than 1 cm
  • Femoral offset discrepancy of less than 25%
  • Exclusion Criteria:
  • Neuromuscular disorders

About Sahlgrenska University Hospital

Sahlgrenska University Hospital, a leading healthcare institution in Sweden, is at the forefront of clinical research and innovation. Affiliated with the University of Gothenburg, the hospital integrates advanced medical care with cutting-edge research, facilitating a collaborative environment for scientific exploration and clinical trials. With a commitment to improving patient outcomes, Sahlgrenska University Hospital focuses on a wide range of therapeutic areas, leveraging its multidisciplinary expertise to advance healthcare solutions. The institution is dedicated to fostering ethical research practices and ensuring the highest standards of patient safety and care in all clinical trials.

Locations

Mölndal, , Sweden

Patients applied

0 patients applied

Trial Officials

Georgios Tsikandylakis, MD, PhD

Principal Investigator

Sahlgrenska University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials